abstract |
Monoclonal antibody that is capable of specifically binding to the K2 domain of tissue factor pathway inhibitor (TFPI), wherein said antibody is capable of specifically binding to an epitope comprising residue R17 of SEQ ID NO: 2 and the KD of said antibody is less than 0.8 nM, as determined using surface plasmon resonance. |